Pages that link to "Q54574335"
Jump to navigation
Jump to search
The following pages link to Opposite Changes in Serum Soluble CD8 in Patients at the Active Stages of Graves' and Hashimoto's Diseases (Q54574335):
Displaying 9 items.
- Toxicities of immunosuppressive treatment of autoimmune neurologic diseases (Q34257903) (← links)
- Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis (Q35208773) (← links)
- Review: Innovative monoclonal antibody therapies in multiple sclerosis (Q37823315) (← links)
- Soluble CD4 concentrations predict relapse of post-partum thyroiditis (Q40655139) (← links)
- Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease? (Q50584004) (← links)
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis (Q61651685) (← links)
- Relation of CD30 Molecules on T-Cell Subsets to the Severity of Autoimmune Thyroid Disease (Q73348291) (← links)
- Lower concentration of serum soluble CD8 in severe Hashimoto's disease (Q80473582) (← links)
- Soluble CD27 in thyroid disorders (Q93915090) (← links)